Colfax Corp. (CFX) Tops Q3 EPS by 1c, Reaffirms Outlook

Colfax Corp. (NYSE: CFX) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $844.5 million versus the consensus estimate of $901.07 million.

GUIDANCE:

Colfax Corp. sees FY2017 EPS of $1.65-$1.75 versus consensus of $1.72

"For 2017, the Company expects $1.34 to $1.44 of net income per diluted share and reaffirms its outlook of $1.65 to $1.75 of adjusted net income per share. This outlook includes a full year contribution from the Fluid Handling business of $0.25 to $0.28, which excludes the expected gain on the divestiture. The Company does not expect any contributions to 2017 adjusted net income per share from recently closed acquisitions."

For earnings history and earnings-related data on Colfax Corp. (CFX) click here.

You May Also Be Interested In

• Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
• ImmuCell reports 46% sales increase in Q3 2026
• Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance